Although stringent post hoc multiple comparisons at single time points did not reach statistical significance, the overall longitudinal trajectory of this ratio remained significantly lower in the telmisartan-treated group, as confirmed by the two-way ANOVA ( Figure 1 E).
← all excerpts
Single-Cell Transcriptomics Reveals Immune Modulation by Telmisartan in Colorectal Cancer.
1
—
—